Carfilzomib, lenalidomide, and dexamethasone for relapsed multiple myeloma

  1. Stewart, A.K.
  2. Rajkumar, S.V.
  3. Dimopoulos, M.A.
  4. Masszi, T.
  5. Špicka, I.
  6. Oriol, A.
  7. Hajek, R.
  8. Rosinol, L.
  9. Siegel, D.S.
  10. Mihaylov, G.G.
  11. Goranova-Marinova, V.
  12. Rajnics, P.
  13. Suvorov, A.
  14. Niesvizky, R.
  15. Jakubowiak, A.J.
  16. San-Miguel, J.F.
  17. Ludwig, H.
  18. Wang, M.
  19. Maisnar, V.
  20. Minarik, J.
  21. Bensinger, W.I.
  22. Mateos, M.-V.
  23. Ben-Yehuda, D.
  24. Kukreti, V.
  25. Zojwalla, N.
  26. Tonda, M.E.
  27. Yang, X.
  28. Xing, B.
  29. Moreau, P.
  30. Palumbo, A.
  31. Show all authors +
Journal:
New England Journal of Medicine

ISSN: 1533-4406 0028-4793

Year of publication: 2015

Volume: 372

Issue: 2

Pages: 142-152

Type: Article

DOI: 10.1056/NEJMOA1411321 GOOGLE SCHOLAR

Sustainable development goals